Scamfluencers Listen Now: Business Wars | The Race to Ozempic
4 snips
Nov 25, 2025 Explore the thrilling battle for dominance in the world of weight-loss drugs. Discover how authorities recently seized counterfeit semaglutide in a high-profile raid. Delve into the alarming rise of unregulated online pharmacies pushing dangerous knockoffs. Learn about Novo Nordisk's struggle to safeguard the integrity of Ozempic amidst fierce competition with Eli Lilly, all set against a backdrop of a staggering $28 billion market. Uncover the real stakes driving these pharmaceutical titans.
AI Snips
Chapters
Transcript
Episode notes
Demand Spike Created Black Market
- Surging consumer demand for Ozempic outpaced supply, driven partly by celebrity and influencer promotion.
- That imbalance created market pressure that opened space for dangerous alternatives and counterfeiters.
Massive Raid Finds Fake Semaglutide
- David Brown recounts an FDA and Customs raid on a Cincinnati shipping yard that uncovered thousands of vials labeled semaglutide.
- The agents seized about 17,000 unregulated vials that could be fake and dangerous, highlighting the scale of the illegal supply.
Counterfeits Threaten Safety And Trust
- The fake vials flood the black market and threaten public safety while their contents remain unknown.
- Novo Nordisk and regulators view knockoffs as a threat to both patient safety and the original drug's reputation.